↓ Skip to main content

Rationale and design of DECISION: a double-blind, randomized, placebo-controlled phase III trial evaluating the efficacy and safety of sorafenib in patients with locally advanced or metastatic…

Overview of attention for article published in BMC Cancer, August 2011
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (66th percentile)
  • Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

policy
1 policy source
twitter
1 X user

Citations

dimensions_citation
87 Dimensions

Readers on

mendeley
102 Mendeley